A new generation of stable, nonantibiotic, low-copy-number plasmids improves immune responses to foreign antigens Salmonella enterica serovar typhi live vectors

Infection and Immunity

Volumn 78, Issue 1, 2010, Pages 337-347

  Galen, James E ^a,b   Wang, Jin Yuan ^a,b   Chinchilla, Magaly ^a,b   Vindurampulle, Christopher ^a,b,c   Vogel, Jeffrey E ^a,b,d   Levy, Haim ^a,b,e   Blackwelder, William C ^a,b   Pasetti, Marcela F ^a,b   Levine, Myron M ^a,b  

^a University of Maryland School of Medicine Center for Vaccine Development   (United States)

^b UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^c Watermark Patent/Trade Mark A   (Australia)

^d EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e ISRAEL INSTITUTE FOR BIOLOGICAL RESEARCH   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL ANTIGEN; BACTERIAL VECTOR; BINDING PROTEIN;

ANIMAL EXPERIMENT; ANTIBODY RESPONSE; ANTIGEN EXPRESSION; ARTICLE; BACILLUS ANTHRACIS; BACTERIAL STRAIN; CHROMOSOME; CONTROLLED STUDY; CYTOPLASM; DNA METABOLISM; FEMALE; IMMUNE RESPONSE; IMMUNIZATION; METABOLISM; MOUSE; NONHUMAN; PARENT; PLASMID; PRIORITY JOURNAL; PURIFICATION; SALMONELLA ENTERICA; SEROTYPE;

ANIMALS; ANTIGENS, BACTERIAL; BACTERIAL PROTEINS; BACTERIAL VACCINES; DNA, SINGLE-STRANDED; GENE EXPRESSION REGULATION, BACTERIAL; HUMANS; IMMUNITY, MUCOSAL; MICE; MUTAGENESIS; PLASMIDS; PROTEIN BINDING; PROTEIN ENGINEERING; SALMONELLA INFECTIONS, ANIMAL; SALMONELLA TYPHI; VACCINES, SYNTHETIC;

EID: 73449141130     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.00916-09     Document Type: Article

References (42)

1. Baillie, L. W., A. L. Rodriguez, S. Moore, H. S. Atkins, C. Feng, J. P. Nataro, and M. F. Pasetti. 2008. Towards a human oral vaccine for anthrax: the utility of a Salmonella Typhi Ty21a-based prime-boost immunization strategy. Vaccine 26:6083-6091.
2. Bennett, P. M. 2008. Plasmid encoded antibiotic resistance: acquisition and transfer of antibiotic resistance genes in bacteria. Br. J. Pharmacol. 153(Suppl. 1):S347-S357.
3. Burrus, V., and M. K. Waldor. 2004. Shaping bacterial genomes with integrative and conjugative elements. Res. Microbiol. 155:376-386.
4. Chase, J. W., and K. R. Williams. 1986. Single-stranded DNA binding proteins required for DNA replication. Annu. Rev. Biochem. 55:103-136.
5. Cranenburgh, R. M., K. S. Lewis, and J. A. Hanak. 2004. Effect of plasmid copy number and lac operator sequence on antibiotic-free plasmid selection by operator-repressor titration in Escherichia coli. J. Mol. Microbiol. Biotechnol. 7:197-203.
6. Dahl, K. H., D. D. Mater, M. J. Flores, P. J. Johnsen, T. Midtvedt, G. Corthier, and A. Sundsfjord. 2007. Transfer of plasmid and chromosomal glycopeptide resistance determinants occurs more readily in the digestive tract of mice than in vitro and exconjugants can persist stably in vivo in the absence of glycopeptide selection. J. Antimicrob. Chemother. 59:478-486.
7. Datsenko, K. A., and B. L. Wanner. 2000. One-step inactivation of chromosomal genes in Escherichia coli K-12 using PCR products. Proc. Natl. Acad. Sci. U. S. A. 97:6640-6645.
8. Deng, W., S. R. Liou, G. Plunkett III, G. F. Mayhew, D. J. Rose, V. Burland, V. Kodoyianni, D. C. Schwartz, and F. R. Blattner. 2003. Comparative genomics of Salmonella enterica serovar Typhi strains Ty2 and CT18. J. Bacteriol. 185:2330-2337.
9. Fang, C. M., J. Y. Wang, M. Chinchilla, M. M. Levine, W. C. Blackwelder, and J. E. Galen. 2008. Use of mchI encoding immunity to the antimicrobial peptide microcin H47 as a plasmid selection marker in attenuated bacterial live vectors. Infect. Immun. 76:4422-4430.
10. Feld, L., S. Schjorring, K. Hammer, T. R. Licht, M. Danielsen, K. Krogfelt, and A. Wilcks. 2008. Selective pressure affects transfer and establishment of a Lactobacillus plantarum resistance plasmid in the gastrointestinal environment. J. Antimicrob. Chemother. 61:845-852.
11. Galán, J. E., K. Nakayama, and R. Curtiss III. 1990. Cloning and characterization of the asd gene of Salmonella typhimurium: use in stable maintenance of recombinant plasmids in Salmonella vaccine strains. Gene 94:29-35.
12. Galen, J. E., M. Chinchilla, M. F. Pasetti, J. Y. Wang, L. Zhao, I. Arciniega-Martinez, D. J. Silverman, and M. M. Levine. 2009. Mucosal immunization with attenuated Salmonella enterica serovar Typhi expressing protective antigen from anthrax toxin (PA83) primes monkeys for accelerated serum antibody responses to parenteral PA83 vaccine. J. Infect. Dis. 199:326-335.
13. Galen, J. E., L. Zhao, M. Chinchilla, J. Y. Wang, M. F. Pasetti, J. Green, and M. M. Levine. 2004. Adaptation of the endogenous Salmonella enterica serovar Typhi clyA-encoded hemolysin for antigen export enhances the immunogenicity of anthrax protective antigen domain 4 expressed by the attenuated live-vector vaccine strain CVD 908-htrA. Infect. Immun. 72:7096-7106.
14. Galen, J. E., O. G. Gomez-Duarte, G. Losonsky, J. L. Halpern, C. S. Lauderbaugh, S. Kaintuck, M. K. Reymann, and M. M. Levine. 1997. A murine model of intranasal immunization to assess the immunogenicity of attenuated Salmonella typhi live vector vaccines in stimulating serum antibody responses to expressed foreign antigens. Vaccine 15:700-708.
15. Galen, J. E., J. Nair, J. Y. Wang, S. S. Wasserman, M. K. Tanner, M. Sztein, and M. M. Levine. 1999. Optimization of plasmid maintenance in the attenuated live vector vaccine strain Salmonella typhi CVD 908-htrA. Infect. Immun. 67:6424-6433.
16. Garmory, H. S., M. W. Leckenby, K. F. Griffin, S. J. Elvin, R. R. Taylor, M. G. Hartley, J. A. Hanak, E. D. Williamson, and R. M. Cranenburgh. 2005. Antibiotic-free plasmid stabilization by operator-repressor titration for vaccine delivery by using live Salmonella enterica serovar Typhimurium. Infect. Immun. 73:2005-2011.
17. Goh, S., and L. Good. 2008. Plasmid selection in Escherichia coli using an endogenous essential gene marker. BMC Biotechnol. 8:61-69.
18. Haines, A. S., P. Akhtar, E. R. Stephens, K. Jones, C. M. Thomas, C. D. Perkins, J. R. Williams, M. J. Day, and J. C. Fry. 2006. Plasmids from freshwater environments capable of IncQ retrotransfer are diverse and include pQKH54, a new IncP-1 subgroup archetype. Microbiology 152:2689-2701.
19. Hone, D. M., A. M. Harris, S. Chatfield, G. Dougan, and M. M. Levine. 1991. Construction of genetically defined double aro mutants of Salmonella typhi. Vaccine 9:810-816.
20. Kang, H. Y., and R. Curtiss III. 2003. Immune responses dependent on antigen location in recombinant attenuated Salmonella typhimurium vaccines following oral immunization. FEMS Immunol. Med. Microbiol. 37:99-104.
21. Karami, N., A. Martner, V. I. Enne, S. Swerkersson, I. Adlerberth, and A. E. Wold. 2007. Transfer of an ampicillin resistance gene between two Escherichia coli strains in the bowel microbiota of an infant treated with antibiotics. J. Antimicrob. Chemother. 60:1142-1145.
22. Karem, K. L., J. Bowen, N. Kuklin, and B. T. Rouse. 1997. Protective immunity against herpes simplex virus (HSV) type 1 following oral administration of recombinant Salmonella typhimurium vaccine strains expressing HSV antigens. J. Gen. Virol. 78:427-434.
23. Khan, S., S. Chatfield, R. Stratford, J. Bedwell, M. Bentley, S. Sulsh, R. Giemza, S. Smith, E. Bongard, C. A. Cosgrove, J. Johnson, G. Dougan, G. E. Griffin, J. Makin, and D. J. Lewis. 2007. Ability of SPI2 mutant of S. typhi to effectively induce antibody responses to the mucosal antigen enterotoxigenic E. coli heat labile toxin B subunit after oral delivery to humans. Vaccine 25:4175-4182.
24. Kotloff, K. L., M. F. Pasetti, E. M. Barry, J. P. Nataro, S. S. Wasserman, M. B. Sztein, W. D. Picking, and M. M. Levine. 2004. Deletion in the Shigella enterotoxin genes further attenuates Shigella flexneri 2a bearing guanine auxotrophy in a phase 1 trial of CVD 1204 and CVD 1208. J. Infect. Dis. 190:1745-1754.
25. Kotloff, K. L., J. K. Simon, M. F. Pasetti, M. B. Sztein, S. L. Wooden, S. Livio, J. P. Nataro, W. C. Blackwelder, E. M. Barry, W. Picking, and M. M. Levine. 2007. Safety and immunogenicity of CVD 1208S, a live, oral ΔguaBA Δsen Δset Shigella flexneri 2a vaccine grown on animal-free media. Hum. Vaccin. 3:268-275.
26. Kotton, C. N., A. J. Lankowski, N. Scott, D. Sisul, L. M. Chen, K. Raschke, G. Borders, M. Boaz, A. Spentzou, J. E. Galán, and E. L. Hohmann. 2006. Safety and immunogenicity of attenuated Salmonella enterica serovar Typhimurium delivering an HIV-1 Gag antigen via the Salmonella type III secretion system. Vaccine 24:6216-6224.
27. Levine, M. M., J. B. Kaper, H. Lockman, R. E. Black, M. L. Clements, and S. Falkow. 1983. Recombinant DNA risk assessment studies in humans: efficacy of poorly mobilizable plasmids in biologic containment. J. Infect. Dis. 148:699-709.
28. Levine, M. M., J. E. Galen, E. M. Barry, F. Noriega, C. O. Tacket, M. Sztein, S. Chatfield, G. Dougan, G. Losonsky, and K. Kotloff. 1997. Attenuated Salmonella typhi and Shigella as live oral vaccines and as live vectors. Behring Inst. Mitt. 98:120-123.
29. Li, H., S. D. Soroka, T. H. Taylor, Jr., K. L. Stamey, K. W. Stinson, A. E. Freeman, D. R. Abramson, R. Desai, L. X. Cronin, J. W. Oxford, J. Caba, C. Pleatman, S. Pathak, D. S. Schmidt, V. A. Semenova, S. K. Martin, P. P. Wilkins, and C. P. Quinn. 2008. Standardized, mathematical model-based and validated in vitro analysis of anthrax lethal toxin neutralization. J. Immunol. Methods 333:89-106.
30. Lohman, T. M., and M. E. Ferrari. 1994. Escherichia coli single-stranded DNA-binding protein: multiple DNA-binding modes and cooperativities. Annu. Rev. Biochem. 63:527-570.
31. Marshall, B., S. Schluederberg, C. Tachibana, and S. B. Levy. 1981. Survival and transfer in the human gut of poorly mobilizable (pBR322) and of transferable plasmids from the same carrier E. coli. Gene 14:145-154.
32. Pickett, T. E., M. F. Pasetti, J. E. Galen, M. B. Sztein, and M. M. Levine. 2000. In vivo characterization of the murine intranasal model for assessing the immunogenicity of attenuated Salmonella enterica serovar Typhi strains as live mucosal vaccines and as live vectors. Infect. Immun. 68:205-213.
33. Porter, R. D., S. Black, S. Pannuri, and A. Carlson. 1990. Use of the Escherichia coli ssb gene to prevent bioreactor takeover by plasmidless cells. Bio/Technology 8:47-51.
34. Salyers, A. A., A. Gupta, and Y. Wang. 2004. Human intestinal bacteria as reservoirs for antibiotic resistance genes. Trends Microbiol. 12:412-416.
35. Stokes, M. G., R. W. Titball, B. N. Neeson, J. E. Galen, N. J. Walker, A. J. Stagg, D. C. Jenner, J. E. Thwaite, J. P. Nataro, L. W. Baillie, and H. S. Atkins. 2007. Oral administration of a Salmonella enterica-based vaccine expressing Bacillus anthracis protective antigen confers protection against aerosolized B. anthracis. Infect. Immun. 75:1827-1834.
36. Szpirer, C., E. Top., M. Couturier, and M. Mergeay. 1999. Retrotransfer or gene capture: a feature of conjugative plasmids, with ecological and evolutionary significance. Microbiology 145:3321-3329.
37. Tacket, C. O., D. M. Hone, G. A. Losonsky, L. Guers, R. Edelman, and M. M. Levine. 1992. Clinical acceptability and immunogenicity of CVD 908 Salmonella typhi vaccine strain. Vaccine 10:443-446.
38. Tacket, C. O., S. M. Kelley, F. Schodel, G. Losonsky, J. P. Nataro, R. Edelman, M. M. Levine, and R. Curtiss III. 1997. Safety and immunogenicity in humans of an attenuated Salmonella typhi vaccine vector strain expressing plasmid-encoded hepatitis B antigens stabilized by the Asd-balanced lethal vector system. Infect. Immun. 65:3381-3385.
39. Tacket, C. O., M. Sztein, S. S. Wasserman, G. Losonsky, K. Kotloff, T. L. Wyant, J. P. Nataro, R. Edelman, J. G. Perry, P. Bedford, D. Brown, S. Chatfield, G. Dougan, and M. M. Levine. 2000. Phase 2 clinical trial of attenuated Salmonella enterica serovar Typhi oral live vector vaccine CVD 908-htrA in U.S. volunteers. Infect. Immun. 68:1196-1201.
40. Trobos, M., C. H. Lester, J. E. Olsen, N. Frimodt-Moller, and A. M. Hammerum. 2009. Natural transfer of sulphonamide and ampicillin resistance between Escherichia coli residing in the human intestine. J. Antimicrob. Chemother. 63:80-86.
41. Wainwright, L. A., and J. B. Kaper. 1998. EspB and EspD require a specific chaperone for proper secretion from enteropathogenic Escherichia coli. Mol. Microbiol. 27:1247-1260.
42. Wei, J., M. B. Goldberg, V. Burland, M. M. Venkatesan, W. Deng, G. Fournier, G. F. Mayhew, G. Plunkett III, D. J. Rose, A. Darling, B. Mau, N. T. Perna, S. M. Payne, L. J. Runyen-Janecky, S. Zhou, D. C. Schwartz, and F. R. Blattner. 2003. Complete genome sequence and comparative genomics of Shigella flexneri serotype 2a strain 2457T. Infect. Immun. 71: 2775-2786.